AbbVie Sues Over Bids To Market Generic Migraine Drugs
AbbVie and its Allergan unit have filed patent infringement lawsuits against MSN Pharmaceuticals and Hetero in New Jersey federal court, alleging the two pharmaceutical companies are infringing on patents for the...To view the full article, register now.
Already a subscriber? Click here to view full article